LV10087B - Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof and pharmaceutical compositions containing the same - Google Patents

Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof and pharmaceutical compositions containing the same Download PDF

Info

Publication number
LV10087B
LV10087B LVP-92-588A LV920588A LV10087B LV 10087 B LV10087 B LV 10087B LV 920588 A LV920588 A LV 920588A LV 10087 B LV10087 B LV 10087B
Authority
LV
Latvia
Prior art keywords
cyclodextrin
sin
salt
morpholino
inclusion complex
Prior art date
Application number
LVP-92-588A
Other languages
English (en)
Latvian (lv)
Other versions
LV10087A (lv
Inventor
Maria Vikmon
Jozsef Dr Szejtli
Lajos Szente
Jozsef Dr Gaal
Istvan Hermecz
Agnes Horvath
Katalin Marmarosi-Nee-Kellner
Gabor Horvath
Iren Munkacsi
Original Assignee
Chinoin Gyegyszer S Vegy Szeti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyegyszer S Vegy Szeti filed Critical Chinoin Gyegyszer S Vegy Szeti
Publication of LV10087A publication Critical patent/LV10087A/xx
Publication of LV10087B publication Critical patent/LV10087B/lv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/04—1,2,3-Oxadiazoles; Hydrogenated 1,2,3-oxadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
LVP-92-588A 1990-03-28 1992-12-30 Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof and pharmaceutical compositions containing the same LV10087B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU901869A HU212730B (en) 1990-03-28 1990-03-28 Process for producing inclusion complexes of cyclodextrine or its derivative and 3-morpholino-sydnonimine or its salt or its tautomer and pharmaceutical compositions containing them
PCT/HU1991/000013 WO1991014681A1 (en) 1990-03-28 1991-03-28 Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same

Publications (2)

Publication Number Publication Date
LV10087A LV10087A (lv) 1994-05-10
LV10087B true LV10087B (en) 1995-02-20

Family

ID=10956597

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-92-588A LV10087B (en) 1990-03-28 1992-12-30 Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof and pharmaceutical compositions containing the same

Country Status (33)

Country Link
US (1) US5298496A (hu)
EP (1) EP0478732B1 (hu)
JP (1) JP2549961B2 (hu)
KR (1) KR950004706B1 (hu)
CN (1) CN1051081C (hu)
AT (1) ATE170849T1 (hu)
AU (1) AU635835B2 (hu)
BG (1) BG61812B1 (hu)
BR (1) BR9105137A (hu)
CA (1) CA2054213C (hu)
CZ (1) CZ285695B6 (hu)
DE (1) DE69130146T2 (hu)
DK (1) DK0478732T3 (hu)
ES (1) ES2121780T3 (hu)
FI (1) FI104882B (hu)
GE (1) GEP19991743B (hu)
HK (1) HK1011688A1 (hu)
HR (1) HRP920560B1 (hu)
HU (2) HU212730B (hu)
LT (1) LT3257B (hu)
LV (1) LV10087B (hu)
MC (1) MC2186A1 (hu)
MD (1) MD776C2 (hu)
MW (1) MW6891A1 (hu)
NO (1) NO303634B1 (hu)
OA (1) OA09522A (hu)
PL (1) PL165866B1 (hu)
RO (1) RO109336B1 (hu)
RU (1) RU2107695C1 (hu)
SI (1) SI9110909B (hu)
TJ (1) TJ189R3 (hu)
UA (1) UA27242C2 (hu)
WO (1) WO1991014681A1 (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU210921B (en) * 1990-03-28 1995-09-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine formed with cyclodextrines and pharmaceutical compositions containing them
DE4117249C2 (de) * 1991-05-27 1998-05-14 Christian Dr Stief Linsidomin zur Behandlung erektiler Dysfunktionen
HU213200B (en) 1993-05-12 1997-03-28 Chinoin Gyogyszer Es Vegyeszet The cyclodextrin or cyclodextrin derivative cluster complexes of taxol, taxotere, or taxus, pharmaceutical preparations containing them and process for their production
HU218280B (en) * 1994-04-26 2000-07-28 Cyclodextrin inclusion complexes containing sin-1a which are stable intheir solid state, process for their preparation and pharmaceutical compositions containing the comlexes
GB9915231D0 (en) 1999-06-29 1999-09-01 Pfizer Ltd Pharmaceutical complex
FR2805462B1 (fr) * 2000-02-24 2003-08-15 Therabel Res Nouvelle forme galenique orale a liberation prolongee de la molsidomine
AU2001255709A1 (en) * 2000-05-11 2001-11-20 Eastman Chemical Company Acylated cyclodextrin guest inclusion complexes

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1496056A (fr) * 1964-06-08 1967-09-29 Takeda Chemical Industries Ltd Nouveaux composés chimiques du type sydnonimine
DE3221425A1 (de) * 1982-06-07 1983-12-08 Boehringer Ingelheim KG, 6507 Ingelheim Hydrolyseempfindlichen wirkstoff enthaltende, lagerstabile tablette
DE3346638A1 (de) * 1983-12-23 1985-07-04 Cassella Ag, 6000 Frankfurt Photostabilisierung von molsidomin
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
DE3522191A1 (de) * 1985-06-21 1987-01-15 Cassella Ag Photostabilisierung von sydnoniminen
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
JPH0819004B2 (ja) * 1986-12-26 1996-02-28 日清製粉株式会社 徐放性医薬製剤
IT1204725B (it) * 1987-06-17 1989-03-10 Edmond Pharma Srl Complessi di inclusione del dipiridamolo con ciclodestrine
SE8904296D0 (sv) * 1989-12-21 1989-12-21 Pharmacia Ab Transdermal system
AU7574391A (en) * 1990-04-06 1991-10-30 Gerhard Blatt Installation for conditioning concrete blocks

Also Published As

Publication number Publication date
PL165866B1 (pl) 1995-02-28
JPH04506221A (ja) 1992-10-29
MW6891A1 (en) 1993-07-14
HU211648A9 (en) 1995-12-28
BG61812B1 (bg) 1998-06-30
SI9110909A (sl) 1998-06-30
HU901869D0 (en) 1990-07-28
WO1991014681A1 (en) 1991-10-03
FI104882B (fi) 2000-04-28
SI9110909B (sl) 1999-02-28
PL293020A1 (en) 1992-12-28
LTIP387A (en) 1994-09-25
HU212730B (en) 1996-10-28
ATE170849T1 (de) 1998-09-15
CZ285695B6 (cs) 1999-10-13
NO914650L (no) 1991-11-27
MD776B2 (en) 1997-07-31
KR920701183A (ko) 1992-08-11
OA09522A (en) 1992-11-15
MC2186A1 (fr) 1992-09-16
CA2054213A1 (en) 1991-09-29
JP2549961B2 (ja) 1996-10-30
HRP920560A2 (hr) 1994-04-30
MD776C2 (ro) 1998-05-31
TJ189R3 (en) 1998-10-28
ES2121780T3 (es) 1998-12-16
GEP19991743B (en) 1999-09-10
EP0478732A1 (en) 1992-04-08
CZ85291A3 (en) 1993-11-17
HK1011688A1 (en) 1999-07-16
RO109336B1 (ro) 1995-01-30
CN1051081C (zh) 2000-04-05
NO303634B1 (no) 1998-08-10
HUT58110A (en) 1992-01-28
AU7549391A (en) 1991-10-21
BR9105137A (pt) 1992-08-04
HRP920560B1 (en) 1999-12-31
BG95530A (bg) 1993-12-24
FI915570A0 (fi) 1991-11-26
NO914650D0 (no) 1991-11-27
CN1055928A (zh) 1991-11-06
US5298496A (en) 1994-03-29
DK0478732T3 (da) 1999-06-07
KR950004706B1 (ko) 1995-05-04
DE69130146T2 (de) 1999-04-01
CA2054213C (en) 1998-12-01
DE69130146D1 (de) 1998-10-15
MD940334A (en) 1996-10-31
EP0478732B1 (en) 1998-09-09
LV10087A (lv) 1994-05-10
AU635835B2 (en) 1993-04-01
LT3257B (en) 1995-05-25
RU2107695C1 (ru) 1998-03-27
UA27242C2 (uk) 2000-08-15

Similar Documents

Publication Publication Date Title
KR0166088B1 (ko) 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
EP0620828B1 (en) Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
EP0519428A2 (en) Cyclodextrin composition
ES2210769T3 (es) Compuesto con vida de almacenamiento prolongada que comprende ciclodextrina y medicamentos y promedicamentos que se descomponen en componentes insolubles en agua.
US20030092672A1 (en) Amphiphilic macrocyclic derivatives and their analogues
LV10087B (en) Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof and pharmaceutical compositions containing the same
EP0555693A1 (en) Method of producing highly watersoluble cyclodextrin complex
DK1968638T3 (en) Controlled release gels
WO1994002518A9 (en) Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
KR20040106452A (ko) 아미오다론 및 설포알킬 에테르 사이클로덱스트린을함유하는 제제
AU5309794A (en) Pharmaceutical compositions containing nanocapsules
Ahmed et al. Effect of cyclodextrins on the physicochemical properties and antimycotic activity of clotrimazole
KR100357497B1 (ko) 수-불용성또는약간수용성인화합물의수-용해도를향상시키기위한조성물
JP3434828B2 (ja) Ｓｉｎ−１ａシクロデキストリン包接複合体
JP4090496B2 (ja) ナノ炭素担持体の製造方法とその方法で製造されたナノ炭素担持体を用いたそのｄｄｓ薬剤
FI89006B (fi) Foerfarande foer framstaellning av en vaermestabil antibiotikumkomposition
US7259153B2 (en) Drug formulation and delivery using crystalline methylated cyclodextrins
Shehatta Cyclodextrins as enhancers of the aqueous solubility of the anthelmintic drug mebendazole: thermodynamic considerations
JP2582497B2 (ja) Ｎ―エトキシカルボニル―３―モルホリノ―シドノンイミン又はその塩の、シクロデキストリン誘導体を用いて形成される包接錯体、それらの製造法及び該錯体を含有する医薬組成物
BR9601302A (pt) Processo para fabricação de um derivado poliglucosamina covalentement ligado derivado poliglucosamina compostos e composição
CA2428179A1 (en) Compositions of n-(methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides
Singh et al. Pharmaceutical applications of cyclodextrins
JPH0948730A (ja) 水溶性の改善されたベンズイミダゾール系抗潰瘍剤含有安定組成物
JP2004531525A (ja) アニリドとシクロデキストリンとの複合体、その製造および特に異常脂肪血症の治療のための医薬としてのその使用
IE20010428A1 (en) Amphiphilic macrocyclic derivatives and their analogues